Message #7 From:
NewsBot Date: January 2, 2007 10:35:00 AM
LLLI News Lamperd Less Lethal Announces Military Sales Order
SARNIA, Ontario--(BUSINESS WIRE)--Lamperd Less Lethal (OTCBB:LLLI)("Lamperd")
is pleased to announce that we have shipped the second part of a
Military Sales Order on December 20, 2006 destined for Afghanistan. Our
products are now approved for Military use overseas, and we anticipate
additional orders over the next twelve months.
About Lamperd
Lamperd Less Lethal is the developer and manufacturer of a wide range of
leading edge civil defense equipment, including less lethal munitions
such as the WASP round and the Defender series of launchers, as well
acting as a supplier of training and accessories, for the police,
military, private security and corrections markets.
Forward-Looking Statements. This news release contains "forward-looking
statements", as that term is defined in Section 27A of the United States
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. Statements in this press release which are not purely historical
are forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the future,
including the receipt of any additional orders over the next twelve
months. Such factors include, among others, the inherent uncertainties
associated with the development of an early stage company in the
firearms and munitions industry, the extensive regulations that apply to
our company and our products and the entry into new markets for our
products. These forward-looking statements are made as of the date of
this news release, and Lamperd Less Lethal assumes no obligation to
update the forward-looking statements, or to update the reasons why
actual results could differ from those projected in the forward-looking
statements. Although we believe that the beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that such beliefs, plans, expectations or intentions
will prove to be accurate. Investors should consult all of the
information set forth herein and should also refer to the risk factors
disclosure outlined in our periodic reports filed from time-to-time with
the Securities and Exchange Commission.
